KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Liabilities: 2010-2024

Historic Total Liabilities for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $906.9 million.

  • Emergent BioSolutions' Total Liabilities fell 9.38% to $878.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $878.5 million, marking a year-over-year decrease of 9.38%. This contributed to the annual value of $906.9 million for FY2024, which is 22.74% down from last year.
  • According to the latest figures from FY2024, Emergent BioSolutions' Total Liabilities is $906.9 million, which was down 22.74% from $1.2 billion recorded in FY2023.
  • Emergent BioSolutions' Total Liabilities' 5-year high stood at $1.8 billion during FY2022, with a 5-year trough of $906.9 million in FY2024.
  • Over the past 3 years, Emergent BioSolutions' median Total Liabilities value was $1.2 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Per our database at Business Quant, Emergent BioSolutions' Total Liabilities skyrocketed by 32.12% in 2022 and then tumbled by 34.00% in 2023.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Total Liabilities stood at $1.4 billion in 2020, then dropped by 6.27% to $1.3 billion in 2021, then soared by 32.12% to $1.8 billion in 2022, then crashed by 34.00% to $1.2 billion in 2023, then fell by 22.74% to $906.9 million in 2024.